Drug details

Veozah (fezolinetan tablets)

type of NK1 Receptor Antagonists

Veozah (fezolinetant) is a neurokinin 3 (NK3) receptor antagonist indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.

This drug may have the following side effects:

• diarrhea,
• back pain,
• insomnia,
• abdominal pain,
• hot flushes, and
• elevated liver transaminase.

The following drugs are related to Veozah, either as a replacement or used together:

• Climara (estradiol transdermal)
• Climara Pro (estradiol, levonorgestrel transdermal)
• Premarin (conjugated estrogens)
• Premarin Injection (conjugated estrogens for injection)
• Premarin Vaginal Cream (conjugated estrogens vaginal cream)
• Femring (estradiol acetate)
• Vivelle-Dot (estradiol transdermal system)
• Yuvafem (estradiol vaginal inserts)
• Vagifem (estradiol vaginal tablets)
• Ogen (estropipate)
• Osphena (ospemifene tablets)